Literature DB >> 20337363

Early Detection of Tamoxifen-induced Maculopathy in Patients With Low Cumulative Doses of Tamoxifen.

Hyewon Chung, Dongyoon Kim, Sei-Hyun Ahn, June-Gone Kim, Joo Yong Lee, Jong Yoon Lim, Young Hee Yoon.   

Abstract

Pathogenic macula determined by techniques including 3-dimensional optical coherence tomography OCT (3D-OCT), in six breast cancer patients who had received low cumulative doses (4.2 to 9.6 g) of tamoxifen is described. Fluorescein angiography showed varying amounts of foveolar hyperfluorescence. 3-dimensional OCT revealed one or several foveal cystoid spaces in 10 of 12 eyes with or without focal disruption of the photoreceptor transition zones. Time-domain OCT did not indicate cystoid spaces in two of the eyes that clearly showed intraretinal cysts on 3D-OCT. Tiny disruptions of photoreceptor transition zones were also more clearly visible on 3D-OCT. Previous studies have clearly shown retinopathy following long-term or high dosages of tamoxifen. Our results indicate that patients with low cumulative doses of tamoxifen can also suffer visual symptom-related foveal cystoid spaces and/or macular thinning. 3D-OCT is very effective in detecting early subtle changes in tamoxifen-induced maculopathy that can occur in asymptomatic patients. Copyright 2010, SLACK Incorporated.

Entities:  

Year:  2010        PMID: 20337363     DOI: 10.3928/15428877-20100215-06

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  8 in total

Review 1.  Breast cancer medications and vision: effects of treatments for early-stage disease.

Authors:  Alvin Eisner; Shiuh-Wen Luoh
Journal:  Curr Eye Res       Date:  2011-08-05       Impact factor: 2.424

2.  Bilateral macular edema in a patient treated with tamoxifen: a case report and review of the literature.

Authors:  Paraskevas Zafeiropoulos; Panagiotis Nanos; Evangelos Tsigkoulis; Maria Stefaniotou
Journal:  Case Rep Ophthalmol       Date:  2014-12-10

3.  Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience.

Authors:  Ah Ran Cho; Young Hee Yoon; June Gone Kim; Yoon Jeon Kim; Joo Yong Lee
Journal:  J Korean Med Sci       Date:  2018-02-12       Impact factor: 2.153

4.  Docetaxel Retinopathy: A Case Report.

Authors:  Sylvia Nghiem-Buffet; Salomon Yves Cohen; Audrey Giocanti-Auregan
Journal:  Case Rep Ophthalmol       Date:  2017-01-17

5.  Large bilateral foveal cysts in the inner retina of a patient treated with tamoxifen, diagnosed with Fourier-domain optical coherence tomography.

Authors:  Ilias Georgalas; Theodore Paraskevopoulos; Dimitris Papaconstaninou; Dimitiris Brouzas; Chryssanthi Koutsandrea
Journal:  Clin Ophthalmol       Date:  2013-04-10

6.  Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2.

Authors:  Alice Behrens; Ahmed Sallam; John Pemberton; Sami Uwaydat
Journal:  Case Rep Ophthalmol       Date:  2018-01-17

7.  Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use.

Authors:  Abdelrahman M Elhusseiny; Nidhi Relhan; William E Smiddy
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-26

Review 8.  Wide field retinal imaging and the detection of drug associated retinal toxicity.

Authors:  Giulia Corradetti; Sara Violanti; Adrian Au; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2019-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.